Patent · US Active

Hybrid caulimovirus promoters and constructs thereof

US9347069B2 · kind B2 · utility

0Cited by
21References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 29, 2014
Grant dateMay 24, 2016
Priority date
Expiry dateJul 29, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A40/146
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to novel hybrid promoters comprising a caulimovirus promoter operably linked to one or more of an EF1α, Act8, Act2 or Act11 promoter. The present invention also relates to novel DNA constructs comprising at least one expression cassette which comprises the hybrid promoter thereof. The present invention further relates to transgenic plants/seeds comprising such DNA constructs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.